(Q38215724)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24872344%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

title

Viruses versus bacteria-novel approaches to phage therapy as a tool against multidrug-resistant pathogens (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24872344%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

main subject

multiple drug resistance

1 reference

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24872344%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

author name string

Tania Mareike Viertel

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24872344%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

Klaus Ritter

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24872344%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

language of work or name

English

0 references

publication date

28 May 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24872344%20AND%20SRC:MED&resulttype=core&format=json

Journal of Antimicrobial Chemotherapy

19 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24872344%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

volume

69

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24872344%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24872344%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

page(s)

2326-2336

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24872344%20AND%20SRC:MED&resulttype=core&format=json

Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America

19 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU173

Federal funding for the study of antimicrobial resistance in nosocomial pathogens: no ESKAPE

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU173

Phages across the biosphere: contrasts of viruses in soil and aquatic environments

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU173

Bacteriophage therapy: a revitalized therapy against bacterial infectious diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU173

The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU173

Oral T4-like phage cocktail application to healthy adult volunteers from Bangladesh.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU173

Bacteriophage applications: where are we now?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU173

21 January 2018

Bacteriophage therapy

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU173

Bacteriophages as anti-infective agents: recent developments and regulatory challenges.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU173

Human volunteers receiving Escherichia coli phage T4 orally: a safety test of phage therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU173

Quality-controlled small-scale production of a well-defined bacteriophage cocktail for use in human clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU173

Bacteriophage therapy of venous leg ulcers in humans: results of a phase I safety trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU173

A controlled clinical trial of a therapeutic bacteriophage preparation in chronic otitis due to antibiotic-resistant Pseudomonas aeruginosa ; a preliminary report of efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU173

Clinical aspects of phage therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU173

The next generation of bacteriophage therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU173

PEGylation of bacteriophages increases blood circulation time and reduces T-helper type 1 immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU173

An amino acid substitution in a capsid protein enhances phage survival in mouse circulatory system more than a 1000-fold.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU173

Genetically engineered virulent phage banks in the detection and control of emergent pathogenic bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU173

Alteration of tail fiber protein gp38 enables T2 phage to infect Escherichia coli O157:H7.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU173

Site-specific recombination of T2 phage using IP008 long tail fiber genes provides a targeted method for expanding host range while retaining lytic activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU173

Generating a synthetic genome by whole genome assembly: phiX174 bacteriophage from synthetic oligonucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU173

Genome replication, synthesis, and assembly of the bacteriophage T7 in a single cell-free reaction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU173

Therapy of experimental pseudomonas infections with a nonreplicating genetically modified phage

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU173

Lysis-deficient bacteriophage therapy decreases endotoxin and inflammatory mediator release and improves survival in a murine peritonitis model

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU173

Lysis-deficient phages as novel therapeutic agents for controlling bacterial infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU173

Filamentous phage assembly: variation on a protein export theme

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU173

Genetically modified filamentous phage as bactericidal agents: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU173

Genetically engineered phage harbouring the lethal catabolite gene activator protein gene with an inducer-independent promoter for biocontrol of Escherichia coli.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU173

Use of genetically engineered phage to deliver antimicrobial agents to bacteria: an alternative therapy for treatment of bacterial infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU173

Dual-surface-modified bacteriophage MS2 as an ideal scaffold for a viral capsid-based drug delivery system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU173

In vivo characteristics of targeted drug-carrying filamentous bacteriophage nanomedicines

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU173

Targeted drug-carrying bacteriophages as antibacterial nanomedicines

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU173

Development of a novel targeting system for lethal photosensitization of antibiotic-resistant strains of Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU173

The inability of a bacteriophage to infect Staphylococcus aureus does not prevent it from specifically delivering a photosensitizer to the bacterium enabling its lethal photosensitization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU173

Bacteriophage endolysins: a novel anti-infective to control Gram-positive pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU173

Characterization of lytic enzyme open reading frame 9 (ORF9) derived from Enterococcus faecalis bacteriophage phiEF24C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU173

Phage endolysins with broad antimicrobial activity against Enterococcus faecalis clinical strains

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU173

Identification of a broadly active phage lytic enzyme with lethal activity against antibiotic-resistant Enterococcus faecalis and Enterococcus faecium

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU173

Efficient elimination of multidrug-resistant Staphylococcus aureus by cloned lysin derived from bacteriophage phi MR11.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU173

The phage K lytic enzyme LysK and lysostaphin act synergistically to kill MRSA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU173

The recombinant phage lysin LysK has a broad spectrum of lytic activity against clinically relevant staphylococci, including methicillin-resistant Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU173

Synergism between a novel chimeric lysin and oxacillin protects against infection by methicillin-resistant Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU173

A novel chimeric lysin shows superiority to mupirocin for skin decolonization of methicillin-resistant and -sensitive Staphylococcus aureus strains

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU173

The truncated phage lysin CHAP(k) eliminates Staphylococcus aureus in the nares of mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU173

LysGH15, a novel bacteriophage lysin, protects a murine bacteremia model efficiently against lethal methicillin-resistant Staphylococcus aureus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU173

P-27/HP endolysin as antibacterial agent for antibiotic resistant Staphylococcus aureus of human infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU173

Novel bacteriophage lysin with broad lytic activity protects against mixed infection by Streptococcus pyogenes and methicillin-resistant Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU173

Synergistic lethal effect of a combination of phage lytic enzymes with different activities on penicillin-sensitive and -resistant Streptococcus pneumoniae strains

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU173

Phage lytic enzymes as therapy for antibiotic-resistant Streptococcus pneumoniae infection in a murine sepsis model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU173

Characterization of five novel endolysins from Gram-negative infecting bacteriophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU173

Antibacterial activity of Acinetobacter baumannii phage ϕAB2 endolysin (LysAB2) against both gram-positive and gram-negative bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU173

Resistance mechanisms in Pseudomonas aeruginosa and other nonfermentative gram-negative bacteria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU173

A bacteriolytic agent that detects and kills Bacillus anthracis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU173

Prevention and elimination of upper respiratory colonization of mice by group A streptococci by using a bacteriophage lytic enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU173

The phage lytic proteins from the Staphylococcus aureus bacteriophage vB_SauS-phiIPLA88 display multiple active catalytic domains and do not trigger staphylococcal resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU173

Molecular evolution of lytic enzymes of Streptococcus pneumoniae and its bacteriophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU173

Co-therapy using lytic bacteriophage and linezolid: effective treatment in eliminating methicillin resistant Staphylococcus aureus (MRSA) from diabetic foot infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU173

Therapeutic efficacy of bacteriophage and Baytril (enrofloxacin) individually and in combination to treat colibacillosis in broilers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU173

Synergistic action of gentamicin and bacteriophage in a continuous culture population of Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU173

Phages limit the evolution of bacterial antibiotic resistance in experimental microcosms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU173

Structural changes induced by a lytic bacteriophage make ciprofloxacin effective against older biofilm of Klebsiella pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU173

Evolutionary dynamics of separate and combined exposure of Pseudomonas fluorescens SBW25 to antibiotics and bacteriophage

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU173

Restricting ciprofloxacin-induced resistant variant formation in biofilm of Klebsiella pneumoniae B5055 by complementary bacteriophage treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU173

Bacteriophage therapy: potential uses in the control of antibiotic-resistant pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU173

Bacteriophage-host interaction: from splendid isolation into a messy reality

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU173

Engineered bacteriophage targeting gene networks as adjuvants for antibiotic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU173

Phage-Antibiotic Synergy (PAS): beta-lactam and quinolone antibiotics stimulate virulent phage growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU173

Synergistic phage-antibiotic combinations for the control of Escherichia coli biofilms in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU173

Phage-antibiotic synergism: a possible approach to combatting Pseudomonas aeruginosa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU173

Phages and the evolution of bacterial pathogens: from genomic rearrangements to lysogenic conversion

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU173

Reversing bacterial resistance to antibiotics by phage-mediated delivery of dominant sensitive genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU173

Increased survival of antibiotic-resistant Escherichia coli inside macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU173

Prevalence of quinolone resistance and mutations in the topoisomerase genes in Salmonella enterica serotype Enteritidis isolates from Serbia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU173

Tellurite: history, oxidative stress, and molecular mechanisms of resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU173

Altered spectrum of multidrug resistance associated with a single point mutation in the Escherichia coli RND-type MDR efflux pump YhiV (MdtF).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU173

Broad-specificity efflux pumps and their role in multidrug resistance of Gram-negative bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU173

Bacteriophage selection against a plasmid-encoded sex apparatus leads to the loss of antibiotic-resistance plasmids

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU173

Fight evolution with evolution: plasmid-dependent phages with a wide host range prevent the spread of antibiotic resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU173

Human skin microbiota: high diversity of DNA viruses identified on the human skin by high throughput sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU173

Prevalence of Staphylococcus aureus and lack of its lytic bacteriophages in the anterior nares of patients and healthcare workers at a rural clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU173

Staphylococcus epidermidis bacteriophages from the anterior nares of humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU173

Nasal carriage of methicillin-resistant Staphylococcus aureus among preclinical medical students: epidemiologic and molecular characteristics of methicillin-resistant S. aureus clones

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU173

Metagenomic analysis of respiratory tract DNA viral communities in cystic fibrosis and non-cystic fibrosis individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU173

Metagenomic detection of phage-encoded platelet-binding factors in the human oral cavity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU173

Evidence of a robust resident bacteriophage population revealed through analysis of the human salivary virome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU173

Bacteriophage isolation from human saliva

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU173

Microviridae goes temperate: microvirus-related proviruses reside in the genomes of Bacteroidetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU173

Diversity and abundance of single-stranded DNA viruses in human feces.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU173

The human gut virome: inter-individual variation and dynamic response to diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU173

Viruses in the faecal microbiota of monozygotic twins and their mothers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU173

CRISPR targeting reveals a reservoir of common phages associated with the human gut microbiome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU173

Study of the viral and microbial communities associated with Crohn's disease: a metagenomic approach.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU173

Metagenomic analyses of an uncultured viral community from human feces

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU173

Rapid evolution of the human gut virome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU173

Metagenomic analysis of the human distal gut microbiome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU173

Identification of predominant culturable vaginal Lactobacillus species and associated bacteriophages from women with and without vaginal discharge syndrome in South Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU173

The phage-host arms race: shaping the evolution of microbes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU173

Method for discovering novel DNA viruses in blood using viral particle selection and shotgun sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU173

Phage as a modulator of immune responses: practical implications for phage therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU173

Direct metagenomic detection of viral pathogens in nasal and fecal specimens using an unbiased high-throughput sequencing approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU173

Emerging view of the human virome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU173

The prospect for bacteriophage therapy in Western medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU173

Secrets of success of a human pathogen: molecular evolution of pandemic clones of meticillin-resistant Staphylococcus aureus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU173

A bacteriophage encodes its own CRISPR/Cas adaptive response to evade host innate immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU173

Bacteriophage adhering to mucus provide a non-host-derived immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU173

Sticky bacteriophage protect animal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU173

Novel Chimerical Endolysins with Broad Antimicrobial Activity Against Methicillin-Resistant Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU173

Dysbiosis in inflammatory bowel disease: a role for bacteriophages?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU173